Clinical Trial Update: Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer [NA]

View source ↗

Summary

A clinical trial is evaluating cryoablation with or without serplulimab for Stage I-IIA non-small cell lung cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-small Cell Lung Cancer | NA | Status: NOT_YET_RECRUITING